Related Experiment Videos
Possible mechanism of action of beta-lactam-enhancing factor on methicillin-resistant Staphylococcus aureus
Y Tajima1, Z Nagasawa, I Tanabe
1Clinical Laboratory, Saga Medical School Hospital, Japan.
Abstract:
We have recently found a factor (Factor T) in aged mixtures of tungstate and phosphate which greatly enhances the antibacterial effects of beta-lactams on methicillin-resistant strains of staphylococcal species such as methicillin-resistant Staphylococcus aureus (MRSA), but shows only weak effects on methicillin-susceptible S. aureus and bacterial strains other than staphylococci. Factor T alone did not strongly inhibit cell metabolism and bacterial growth unless an excess amount was added. When Factor T was added to the culture medium beforehand, the growth of MRSA cells was rapidly suppressed just after addition of oxacillin (MPIPC). However, the growth of the cells was inhibited gradually when these two reagents were added in reverse order. For full expression of the enhancing effect, it seemed necessary for cells of MRSA strains to be incubated with Factor T for at least 2-3 hr. When the cells were washed after being sensitized by incubating them for 5 hr with Factor T, it took approximately 1 hr for the cells to recover their resistance to MPIPC. Factor T reduced the amount of penicillin-binding protein-2' (PBP 2'), and thus sensitized the MRSA strains to beta-lactams.
Insights
A novel factor (Factor T) enhances beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). This discovery offers a new strategy to combat dangerous MRSA infections.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat due to its resistance to common antibiotics.
- Beta-lactam antibiotics are a cornerstone of antibacterial therapy, but their efficacy against MRSA is limited.
- There is an urgent need for novel strategies to overcome MRSA resistance to beta-lactams.
Purpose of the Study:
- To investigate a newly identified factor (Factor T) for its potential to enhance the antibacterial activity of beta-lactams against MRSA.
- To elucidate the mechanism by which Factor T exerts its effects on MRSA.
Main Methods:
- Factor T, derived from aged tungstate and phosphate mixtures, was tested for its synergistic effects with beta-lactam antibiotics (e.g., oxacillin/MPIPC) on various bacterial strains.
- MRSA and methicillin-susceptible S. aureus (MSSA) were cultured with Factor T and beta-lactams in different sequences and incubation times.
- Bacterial growth inhibition, cell metabolism, and penicillin-binding protein-2' (PBP 2') levels were assessed.
Main Results:
- Factor T significantly enhanced the antibacterial effects of beta-lactams specifically against MRSA strains, with minimal impact on MSSA or other bacteria.
- Pre-incubation of MRSA with Factor T before beta-lactam addition resulted in rapid growth suppression.
- Factor T was found to reduce the levels of penicillin-binding protein-2' (PBP 2'), a key factor in MRSA resistance, thereby sensitizing MRSA to beta-lactams.
Conclusions:
- Factor T is a potent enhancer of beta-lactam activity against MRSA.
- The mechanism involves the reduction of PBP 2', restoring MRSA susceptibility to beta-lactams.
- Factor T represents a promising therapeutic adjunct for treating MRSA infections.